| Item Type | Name |
|
Academic Article
|
Combination therapy for dyslipidemia: safety and regulatory considerations.
|
|
Academic Article
|
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
|
|
Academic Article
|
Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia.
|
|
Academic Article
|
Ezetimibe: a novel option for lowering cholesterol.
|
|
Academic Article
|
Striated muscle safety of ezetimibe/simvastatin (Vytorin).
|
|
Academic Article
|
Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
|
|
Academic Article
|
Combination therapy in the management of complex dyslipidemias.
|
|
Academic Article
|
Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
|
|
Academic Article
|
Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
|
|
Academic Article
|
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
|
|
Academic Article
|
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
|
|
Academic Article
|
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
|
|
Academic Article
|
Statin and ezetimibe combination therapy in cardiovascular disease.
|
|
Academic Article
|
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
|
|
Academic Article
|
Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
|
|
Academic Article
|
Cholesterol absorption blockade with ezetimibe.
|
|
Academic Article
|
Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses.
|
|
Academic Article
|
Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
|
|
Academic Article
|
Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
|
|
Academic Article
|
Newer pharmaceutical agents to treat lipid disorders.
|
|
Academic Article
|
Is it over for ezetimibe?
|
|
Academic Article
|
Therapies targeting exogenous cholesterol uptake: new insights and controversies.
|
|
Academic Article
|
Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein.
|
|
Academic Article
|
Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia?
|
|
Academic Article
|
Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?
|
|
Academic Article
|
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
|
|
Academic Article
|
The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
|
|
Academic Article
|
Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention.
|
|
Academic Article
|
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.
|
|
Academic Article
|
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.
|
|
Academic Article
|
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy.
|
|
Concept
|
Ezetimibe, Simvastatin Drug Combination
|
|
Concept
|
Ezetimibe
|
|
Academic Article
|
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
|
|
Academic Article
|
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
|